Prostate-specific antigen spikes with ¹³¹Cs brachytherapy. Is there a difference with other radioisotopes?

@article{Beriwal2012ProstatespecificAS,
  title={Prostate-specific antigen spikes with ¹³¹Cs brachytherapy. Is there a difference with other radioisotopes?},
  author={Sushil Beriwal and Ryan P. Smith and Chris Houser and Ronald M. Benoit},
  journal={Brachytherapy},
  year={2012},
  volume={11 6},
  pages={457-9}
}
PURPOSE There is a suggestion that a dose-rate effect exists for the prostate-specific antigen (PSA) spike after brachytherapy. ¹³¹Cs is a newer radioisotope with a half-life of 9.7 days that is being used for prostate brachytherapy. There is no published data on the PSA spike with this radioisotope and the goal of this study was to quantify PSA spikes with… CONTINUE READING